Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Purchase of Investments (2019 - 2026)

Updated

Analysis

Abvc Biopharma (ABVC) Purchase of Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 258.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 919.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 300.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.40 Bn
10 Abvc Biopharma 24.28 Mn 21.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,597.00
Mar 31, 2026 680,000.00
Dec 31, 2023 -154,173.00
Sep 30, 2023 52,583.00
Dec 31, 2022 83,199.00
Dec 31, 2021 -426,846.00
Sep 30, 2021 793,335.00
Jun 30, 2021 140,022.00
Mar 31, 2021 281,952.00
Dec 31, 2019 110.00
Sep 30, 2019 -55.00
Jun 30, 2019 -55.00
Mar 31, 2019 17,801.00
API Access

Abvc Biopharma Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY